Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative representative of a severe respiratory illness resulted in widespread human infections and deaths in nearly all of the countries since late 2019. There is no therapeutic FDA-approved drug against SARS-CoV-2 infection, alth...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Biomol Struct Dyn
Hlavní autoři: Babadaei, Mohammad Mahdi Nejadi, Hasan, Anwarul, Vahdani, Yasaman, Bloukh, Samir Haj, Sharifi, Majid, Kachooei, Ehsan, Haghighat, Setareh, Falahati, Mojtaba
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7256352/
https://ncbi.nlm.nih.gov/pubmed/32397906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1767210
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky